AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
3.40
-0.07 (-2.02%)
At close: Jun 20, 2025, 3:59 PM
3.34
-1.62%
Pre-market: Jun 23, 2025, 06:44 AM EDT
-2.02% (1D)
| Bid | 3.33 |
| Market Cap | 1.01B |
| Revenue (ttm) | 23.11M |
| Net Income (ttm) | -167.87M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -6.06 |
| Forward PE | -6.31 |
| Analyst | Buy |
| Ask | 3.38 |
| Volume | 8,144,234 |
| Avg. Volume (20D) | 4,823,917 |
| Open | 3.50 |
| Previous Close | 3.47 |
| Day's Range | 3.24 - 3.54 |
| 52-Week Range | 1.89 - 3.68 |
| Beta | 0.36 |
About ABCL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABCL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABCL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
AbCellera Biologics Inc. is scheduled to release its earnings on Aug 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+15.94%
Shares of healthcare technology stocks are trading...
Unlock content with
Pro Subscription
3 months ago
-11.3%
AbCellera Biologics shares are trading lower after the company reported worse-than-expected Q4 sales results. Also, Stifel cut its price target on the stock from $12 to $10.
